Natural course of pollen‐induced allergic rhinitis from childhood to adulthood: A 20‐year follow up
Authors:
- Magnus LindqvistMLMagnus Lindqvist
- Katja Biering Leth‐MøllerKLKatja Biering Leth‐Møller
- Allan LinnebergAllan Linneberg
- Inger KullIKInger Kull
- Anna BergströmABAnna Bergström
- Antonios GeorgellisAGAntonios Georgellis
- Magnus P. BorresMBMagnus P. Borres
- Agneta EkebomAEAgneta Ekebom
- Marianne van HageMHMarianne van Hage
- Erik MelénEMErik Melén
- Marit WestmanMWMarit Westman
Open Access
Abstract
Background: Allergic rhinitis (AR) is one of the most common chronic diseases worldwide. There are limited prospective long‐term data regarding persistency and remission of AR. The objective of this study was to investigate the natural course of pollen‐induced AR (pollen‐AR) over 20 years, from childhood into early adulthood.Methods: Data from 1137 subjects in the Barn/Children Allergi/Allergy Milieu Stockholm Epidemiologic birth cohort (BAMSE) with a completed questionnaire regarding symptoms, asthma, treatment with allergen immunotherapy (AIT) and results of allergen‐specific IgE for inhalant allergens at 4, 8, 16 and 24 years were analyzed. Pollen‐AR was defined as sneezing, runny, itchy or blocked nose; and itchy or watery eyes when exposed to birch and/or grass pollen in combination with allergen‐specific IgE ≥0.35kUA/L to birch and/or grass.Results: Approximately 75% of children with pollen‐AR at 4 or 8 years had persistent disease up to 24 years, and 30% developed asthma. The probability of persistency was high already at low levels of pollen‐specific IgE. The highest rate of remission from pollen‐AR was seen between 16 and 24 years (21.5%); however, the majority remained sensitized. This period was also when pollen‐specific IgE‐levels stopped increasing and the average estimated annual incidence of pollen‐AR decreased from 1.5% to 0.8% per year.Conclusion: Children with pollen‐AR are at high risk of persistent disease for at least 20 years. Childhood up to adolescence seems to be the most dynamic period of AR progression. Our findings underline the close cross‐sectional and longitudinal relationship between sensitization, AR and asthma.Keywords
All Related Versions
Funding Information
- Ellen, Walter and Lennart Hesselman Foundation for Scientific Research
- European Commission
- Forskningsrådet för hälsa, arbetsliv och välfärd
- Hjärt-Lungfonden
- Konsul Th C Berghs Stiftelse
- Magnus Bergvalls Stiftelse
- Stiftelsen Acta Oto-Laryngologica
- Stiftelsen Konung Gustaf V:s 80-årsfond
- Vetenskapsrådet
This publication has 41 references indexed in Scilit:
- SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trialJournal of Allergy and Clinical Immunology, 2012
- The influence of gender and atopy on the natural history of rhinitis in the first 18 years of lifeClinical & Experimental Allergy, 2011
- Sensitization to inhalant allergens between 4 and 8 years of age is a dynamic process: results from the BAMSE birth cohortClinical & Experimental Allergy, 2008
- Are We Getting Enough Allergens?International Archives of Allergy and Immunology, 2008
- Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal studyJournal of Allergy and Clinical Immunology, 2007
- Specific immunotherapy has long‐term preventive effect of seasonal and perennial asthma: 10‐year follow‐up on the PAT studyAllergy, 2007
- Incidence and remission of self‐reported allergic rhinitis symptoms in adultsAllergy, 2006
- Rhinovirus illnesses during infancy predict subsequent childhood wheezingJournal of Allergy and Clinical Immunology, 2005
- The natural history of respiratory allergy: A follow-up study of 99 patients up to 10 yearsRespiratory Medicine, 2001
- Long-Term Risk Factors for Developing Asthma and Allergic Rhinitis: A 23-Year Follow-Up Study of College StudentsAllergy and Asthma Proceedings, 1994